- Home
- STHO vs MDXH Comparison
STHO vs MDXH Comparison
Compare STHO & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STHO
- MDXH
- Stock Information
- Founded
- STHO N/A
- MDXH 2003
- Country
- STHO United States
- MDXH Belgium
- Employees
- STHO N/A
- MDXH N/A
- Industry
- STHO Real Estate
- MDXH
- Sector
- STHO Real Estate
- MDXH
- Exchange
- STHO Nasdaq
- MDXH Nasdaq
- Market Cap
- STHO 89.7M
- MDXH 73.3M
- IPO Year
- STHO N/A
- MDXH 2021
- Fundamental
- Price
- STHO $6.53
- MDXH $1.87
- Analyst Decision
- STHO
- MDXH Buy
- Analyst Count
- STHO 0
- MDXH 1
- Target Price
- STHO N/A
- MDXH $6.00
- AVG Volume (30 Days)
- STHO 93.2K
- MDXH 49.3K
- Earning Date
- STHO 05-20-2025
- MDXH 05-14-2025
- Dividend Yield
- STHO N/A
- MDXH N/A
- EPS Growth
- STHO N/A
- MDXH N/A
- EPS
- STHO N/A
- MDXH N/A
- Revenue
- STHO $113,297,000.00
- MDXH $90,049,000.00
- Revenue This Year
- STHO N/A
- MDXH $23.38
- Revenue Next Year
- STHO N/A
- MDXH $16.84
- P/E Ratio
- STHO N/A
- MDXH N/A
- Revenue Growth
- STHO N/A
- MDXH 28.29
- 52 Week Low
- STHO $6.09
- MDXH $1.35
- 52 Week High
- STHO $14.50
- MDXH $3.50
- Technical
- Relative Strength Index (RSI)
- STHO 42.45
- MDXH 68.09
- Support Level
- STHO $6.11
- MDXH $1.67
- Resistance Level
- STHO $7.02
- MDXH $1.82
- Average True Range (ATR)
- STHO 0.35
- MDXH 0.10
- MACD
- STHO 0.06
- MDXH 0.01
- Stochastic Oscillator
- STHO 46.41
- MDXH 86.14
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.